Sodium-glucose co-transporter 2 Inhibitors Act Independently of <i>SGLT2</i> to Confer Benefit for Heart Failure with Reduced Ejection Fraction in Mice
Justin H. Berger(Children's Hospital of Philadelphia), Daniel P. Kelly(Cardiovascular Institute of the South), Ling Lai(University of Pennsylvania), Jiten Patel(University of Pennsylvania), Saptarsi M. Haldar(Amgen (United States)), Caitlyn E. Bowman(Williams College), Renee Taing(University of Pennsylvania), Teresa C. Leone(Cardiovascular Institute of the South), Zoltàn Arany(Cardiovascular Institute Hospital), Timothy Matsuura(University of Minnesota System), Jeffrey D. Reagan(Amgen (United States))
Cited by 6
Related Papers
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|765